Verici DX (VRCI)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

 8.00p
   
  • Change Today:
      0.000p
  • 52 Week High: 17.50
  • 52 Week Low: 5.75
  • Currency: UK Pounds
  • Shares Issued: 242.54m
  • Volume: 208,571
  • Market Cap: £19.40m
  • RiskGrade: 429

Verici DX Overview

Verici was incorporated in April 2020 as a wholly-owned subsidiary of Renalytix AI plc ("RENX"), the AIM-quoted developer of artificial intelligence decision support and clinical management tools for improving early diagnosis, continual monitoring and drug development for kidney disease. The Company develops tests to understand how a patient is likely and may be responding to kidney transplant.
Competitors: ValiRx, e-Therapeutics, Genflow Biosciences , Oxford Biodynamics

Key Personnel

CEO: Sara Barrington
Non-Executive Chairman: Julian Baines
Senior Independent Non-Executive Director: Ian James Carruthers
Non-Executive Dir: Erik Kristian Lium, Lorenzo Gallon, James Renwick McCullough

Contact Details

Address: Avon House, 19 Stanwell Road, Penarth, Cardiff, United Kingdom, CF64 2EZ
Phone: +44 (0)29 2071 0570
Website: http://www.vericidx.com/

Listings

Sector: Pharma and Biotech(LSE)
Index: FTSE AIM All-Share
ISIN: GB00BM8HZD43

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Verici DX Market Data

Currency UK Pounds
Share Price 8.00p
Change Today 0.000p
% Change 0.00 %
52 Week High 17.50
52 Week Low 5.75
Volume 208,571
Shares Issued 242.54m
Market Cap £19.40m
RiskGrade 429

Verici DX Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
35.8% below the market average35.8% below the market average35.8% below the market average35.8% below the market average35.8% below the market average
20.75% below the sector average20.75% below the sector average20.75% below the sector average20.75% below the sector average20.75% below the sector average
Price Trend
53.33% below the market average53.33% below the market average53.33% below the market average53.33% below the market average53.33% below the market average
1.75% above the sector average1.75% above the sector average1.75% above the sector average1.75% above the sector average1.75% above the sector average
Income Not Available
Growth Not Available

Verici DX Dividends

No dividends found

Trades for 23-Apr-2024

Time Volume / Share Price
15:27 12,997 @ 7.73p
12:32 2,500 @ 7.73p
11:49 39,225 @ 8.00p
11:20 26,084 @ 7.73p
11:11 20,000 @ 8.00p

Verici DX Key Personnel

CEO Sara Barrington

Top of Page